The Health Resources and Services Administration, an agency of the U.S. Department of Health and Human Services, issued a Request for Information (RFI) to gather public comment on workforce training and care delivery models for administering potential future FDA-approved psychedelic therapies in ambulatory clinical settings. In their 20-page response, Reason for Hope and VMHLC emphasized: "The task is not to choose between rigor and compassion, safety and access, human care